Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2310 Views
-
Last post by NHE
-
- 6 Replies
- 6594 Views
-
Last post by ElliotB
-
- 0 Replies
- 1340 Views
-
Last post by NHE
-
- 0 Replies
- 3432 Views
-
Last post by NHE
-
- 1 Replies
- 1023 Views
-
Last post by NHE
-
- 1 Replies
- 1517 Views
-
Last post by NHE
-
- 11 Replies
- 3372 Views
-
Last post by NHE
-
- 0 Replies
- 3162 Views
-
Last post by NHE
-
- 0 Replies
- 1375 Views
-
Last post by NHE